Nuclear factor-kappa B (NF-jB) inhibits cell death through suppression of the caspase cascade, the c-Jun N-terminal kinase (JNK) pathway, and reactive oxygen species (ROS) accumulation. To suppress this antiapoptotic function of NF-jB might be a promising strategy to increase susceptibility of tumor cells to stress-induced cell death. We have recently shown that tumor necrosis factor (TNF)a induces caspase-dependent and -independent JNK activation and ROS accumulation in cellular FLICEinhibitory protein (c-Flip) À/À murine embryonic fibroblasts (MEFs). To apply this observation to tumor therapy, we knocked down c-FLIP by RNA interference in various tumor cells. Consistent with the results using c-Flip À/À MEFs, we found that TNFa stimulation induced caspase-dependent prolonged JNK activation and ROS accumulation, followed by apoptotic and necrotic cell death in various tumor cells. Furthermore, TNFa and Fas induced the cleavage of mitogen-activated protein kinase/ ERK kinase kinase (MEKK)1, resulting in generation of a constitutive active form of MEKK1 leading to JNK activation in c-FLIP knockdown cells. Given that ROS accumulation and necrotic cell death enhance inflammation followed by compensatory proliferation of tumor cells, selective suppression of caspase-dependent ROS accumulation will be an alternative strategy to protect cells from ROS-dependent DNA damage and compensatory tumor progression.
Introduction
Nuclear factor-kappa B (NF-kB) plays a pivotal role in protection from tumor necrosis factor (TNF)a-and genotoxic stress-induced apoptosis. A key mechanism by which NF-kB inhibits apoptosis has been considered to enhance transcription of various antiapoptotic genes, including cellular FLICE-inhibitory protein (c-Flip), the members of the Bcl-2 family, and X chromosome-linked inhibitor of apoptosis (Xiap) (Barkett and Gilmore, 1999; Karin and Lin, 2002) . In addition to these, recent studies have shown that NF-kB suppresses TNFa-induced cell death by inhibiting prolonged c-Jun N-terminal kinase (JNK) activation and reactive oxygen species (ROS) accumulation (Sakon et al., 2003; Pham et al., 2004; Ventura et al., 2004; Kamata et al., 2005) . Although various signaling intermediates including ferritin heavy chain and manganese-dependent superoxide dismutase to eliminate ROS accumulation have been identified (Pham et al., 2004; Kamata et al., 2005) , it remains controversial whether their functions are essential and/or sufficient for eliminating ROS accumulation (Nakano et al., 2006) . Moreover, a recent study has shown that activated caspase 3 cleaves the p75 subunit of complex I of the mitochondrial electron transport chain, which would impair the function of complex I, resulting in ROS accumulation (Ricci et al., 2004) . In addition, Giorgio et al. (2005) have shown that proapoptotic signals induce the release of p66
Shc from a putative inhibitory complex and the released p66
Shc then oxidizes reduced cytochrome c, thereby generating ROS. Therefore, the molecular mechanism underlying caspase-dependent ROS accumulation during apoptotic cell death is not fully understood.
c-FLIP, also designated as caspase homologue (CASH) or Casper, was first identified as a molecule that interacts with Fas-associated death domain (FADD) or is structurally related to procaspase 8 (Budd et al., 2006) . c-Flip encodes two splicing variants, c-FLIP L and c-FLIP S . While c-FLIP S only contains two N-terminal death effector domain (DED)s, c-FLIP L consists of the N-terminal DEDs and a C-terminal caspase-like domain that does not possess enzymatic activity. Many studies have shown that both c-FLIP L and c-FLIP S inhibit death receptor-induced apoptosis by binding to and inhibiting caspase 8 activation via DED-DED interaction (Budd et al., 2006) . Consistently, c-Flip À/À murine embryonic fibroblasts (MEFs) showed an increased susceptibility to TNFaand Fas ligand-induced cell death (Yeh et al., 2000) . Very recently, we have shown that TNFa-induced ROS accumulation is enhanced in c-Flip À/À MEFs , indicating that c-FLIP plays a dominant role in suppressing ROS accumulation.
To explore whether downregulation of c-FLIP enhances ROS accumulation in various cell types, we have knocked down endogenous c-FLIP expression by RNA interference (RNAi) in HeLa cells. Consistent with c-Flip À/À MEFs , TNFa and anti-Fas antibody stimulation induced ROS accumulation along with delayed and long-lasting JNK and extracellular signal-regulated kinase (ERK) activation in c-FLIP knockdown HeLa cells. Notably, TNFa-and anti-Fas antibody-induced prolonged JNK and ERK, and ROS accumulation were completely inhibited by a caspase inhibitor, suggesting that these events are downstream of the caspase cascade. Similar observations were also observed in c-FLIP knockdown HCT116 and A549 cells. Interestingly, TNFa induced caspasedependent necrotic as well as apoptotic cell death in a similar kinetics. Moreover, TNFa and Fas induced the cleavage of mitogen-activated protein kinase (MAPK)/ ERK kinase kinase (MEKK)1, resulting in generation of a constitutive active form of MEKK1 leading to JNK activation. Given that accumulated ROS elicits inflammation, resulting in compensatory proliferation of tumor cells, identification of target genes responsible for caspase-dependent ROS accumulation might be crucial to efficiently treat cancers through suppression of caspase-dependent ROS accumulation.
Results

Knockdown of c-FLIP promotes TNFa-induced prolonged JNK activation and ROS accumulation in HeLa cells
Our recent study has shown that TNFa induces caspasedependent and -independent ROS accumulation, and prolonged JNK activation in c-Flip À/À MEFs . To apply this observation to tumor therapy, we first knocked down expression of c-FLIP using small interfering RNA (siRNA) in HeLa cells. While transfection of the control green fluorescent protein (GFP) siRNA oligos did not affect expression of c-FLIP L and c-FLIP S , these bands disappeared in cells transfected with two different pairs of siRNA oligos targeting distinct regions of c-FLIP (Figure 1a) . Transfection of two c-FLIP siRNA oligos did not affect expression of other antiapoptotic proteins including TNF receptor-associated factor (TRAF)2, receptorinteracting protein (RIP) and XIAP ( Figure 1a ). Under these experimental conditions, TNFa-induced JNK activation was dramatically prolonged and continued at 8 h in both c-FLIP siRNA-, but not control siRNAtransfected HeLa cells (Figure 1b) . Moreover, TNFa induced ROS accumulation in both c-FLIP siRNAtransfected HeLa cells (Figure 1c ). Since we obtained similar results using two different c-FLIP siRNAs as described above, we used c-FLIP(a) siRNA oligos hereafter. We also confirmed that knockdown of c-FLIP did not impair the TNFa-induced NF-kB activation, since TNFa-induced degradation of inhibitor of NF-kBa (IkBa) was similarly induced in both control siRNA-and c-FLIP siRNA-transfected HeLa cells (Figure 1d ).
TNFa-induced ROS accumulation and prolonged JNK activation are caspase dependent We next investigated the time course of TNFa-induced JNK activation in more detail. The early phase of TNFa-induced JNK and ERK activation rapidly declined within 1 h in control siRNA-and c-FLIP siRNA-transfected HeLa cells, but the sustained phase of JNK and ERK activation appeared at 2 h and then peaked at 4 h in c-FLIP knockdown HeLa cells (Figure 2a ). We could not detect TNFa-induced phosphorylation of p38 in HeLa cells under these conditions (data not shown). The processing of procaspase 8 was also induced at 2 h and peaked at 4 h, resulting in generation of the p43, p41 and p18 fragments. Collectively, these results demonstrate that knockdown of c-FLIP expression by RNAi is sufficient for TNFa-induced ROS accumulation, and prolonged JNK and ERK activation along with the activation of caspase 8 in HeLa cells. 
Caspase-dependent cleavage of MEKK1 is induced in c-FLIP knockdown cells
Although previous studies have revealed that a critical contribution of ROS to prolonged JNK activation, the kinase(s) responsible for prolonged JNK activation remain to be identified (Sakon et al., 2003; Pham et al., 2004; Ventura et al., 2004) . On the other hand, a previous study has shown that full-length MEKK1 is cleaved by caspase 3 to release the N-terminal inhibitory domain, thereby generating a constitutively active form of MEKK1 (MEKK1DN) (Widmann et al., 1998) . Taken that z-VAD-fmk inhibited prolonged JNK and ERK activation in c-FLIP knockdown HeLa cells, MEKK1 may be a candidate that mediates prolonged JNK and ERK. We first tested whether the proteolytic cleavage of MEKK1 is induced in c-FLIP knockdown HeLa cells after TNFa stimulation. The full-length MEKK1 with a molecular mass of 200 kDa gradually decreased at 2 h, and the C-terminal fragment of MEKK1 with a molecular 
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A Nakajima et al mass of 90 kDa appeared at 4 h and then declined at 8 h ( Figure 4a ). This kinetics of the processing of MEKK1 was well correlated with those of JNK activation ( Figure 2a) . Notably, pretreatment with z-VAD-fmk completely inhibited the TNFa-induced processing of MEKK1, which was also consistent with the inhibitory effect of z-VAD-fmk on JNK and ERK activation (Figures 1b and 4b ). On the other hand, activation of ERK was earlier than the processing of MEKK1, suggesting that a kinase other than MEKK1 might be involved in the caspase-dependent ERK activation. Moreover, anti-Fas antibody stimulation also induced the processing of full-length MEKK1 in a caspasedependent manner in c-FLIP knockdown HeLa cells (Figure 4c) . Similarly, the processing of MEKK1 was induced in c-FLIP knockdown HCT116 and A549 cells after TNFa stimulation (Figures 4d and e) . Together, the caspase-dependent cleavage of MEKK1 may contribute to prolonged JNK activation in c-FLIP knockdown cells.
TNFa-induced prolonged JNK activation is a downstream event of caspase activation and does not play a crucial role in TNFa-induced cell death in c-FLIP knockdown cells To determine whether prolonged JNK activation promotes cell death or is a downstream event of caspase activation, we tested whether a JNK-specific inhibitor, SP600125 inhibits TNFa-induced processing of caspase 8 and cell death. Although TNFa-induced activation of JNK was completely inhibited in the presence of SP600125, SP600125 did not inhibit TNFa-induced processing of procaspase 8 and cell death (Figures 5a  and b) . Together, these results indicate that prolonged JNK activation is a downstream, but not upstream event of activation of caspase (Figure 5a ). Our results clearly showed an essential role for the caspase cascade in JNK activation (Figures 2-4) , prompting us to verify that activation of caspase 8 is required for JNK activation. While z-VAD-fmk completely inhibited JNK activation, a caspase 8-specific inhibitor, Ac-IETD-CHO, even at high concentration (100 mM) only weakly inhibited the processing of caspase 8, TNFa-induced JNK activation and cell death ( Figure 5 ). Thus, we could not conclude that caspase 8 is essential for TNFa-induced JNK activation. Further studies will be required to address this issue.
TNFa induces both apoptotic and necrotic cell death in c-FLIP knockdown cells We and others have previously shown that TNFa induces caspase-dependent apoptosis and ROS-dependent c-FLIP suppresses caspase-dependent JNK and ROS A Nakajima et al necrosis in NF-kB activation-deficient cells (Sakon et al., 2003; Ventura et al., 2004; Kamata et al., 2005) . To investigate whether c-FLIP knockdown HeLa cells die from apoptosis or necrosis upon TNFa stimulation, we examined the morphology of c-FLIP knockdown HeLa cells after TNFa stimulation by transmission electron microscopy. TNFa stimulation alone did not induce cell death in control HeLa cells (data not shown). c-FLIP knockdown HeLa cells showed nuclear condensation and extensive cytoplasmic blebbing, indicating that these cells died from apoptosis ( Figure 6 ). Interestingly, other cells showed prominent vacuolization in the cytoplasm without affecting nuclear morphology, which was consistent with necrotic cell death ( Figure 6 ). Moreover, z-VAD-fmk almost completely inhibited both apoptotic and necrotic cell death in c-FLIP knockdown HeLa cells (Figure 6 ). Similarly, TNFa induced both apoptotic and necrotic cell death in HCT116 and A549 cells, and both types of cell death were completely inhibited in the presence of a caspase inhibitor ( Figure 6 ). Collectively, TNFa induces apoptotic and necrotic cell death in c-FLIP knockdown cells in a caspase-dependent manner.
TNFa induces apoptotic and necrotic cell death in a similar kinetics in c-FLIP knockdown cells
To assess the contribution of apoptosis and necrosis to TNFa-induced cell death more quantitatively, we performed time-course analysis of TNFa-induced DNA hypoploidy as an indication of apoptosis using flow cytometry. In parallel, we also performed lactate dehydrogenase (LDH) release assay to detect released LDH in the culture supernatants from ruptured cells, a hallmark of necrosis. As shown in Figure 7a 
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Discussion
In the present study, we have shown that knockdown of c-FLIP induces caspase-dependent ROS accumulation and prolonged JNK activation, followed by necrotic and apoptotic cell death. Consistent with our study using c-Flip A recent study has shown that one of the mechanisms by which ROS induce prolonged JNK activation is to inactivate MAP kinase phosphatases by oxidizing cysteine residues critical for their phosphatase activities that would otherwise dephosphorylate and inactivate MAPKs . In addition to this mechanism, our present study has demonstrated that activation of the caspase cascade induces the processing of MEKK1, thereby generating a constitutively active form (Figure 4) . These results are consistent with our recent findings, in which c-FLIP L suppresses caspasedependent JNK activation . It is likely that a kinase other than MEKK1 might also contribute to prolonged JNK and ERK activation. Indeed, several kinases including p21-activated kinase2 and mammalian Sterile20-like kinases have been shown to be cleaved by caspases, and activate the JNK pathway (Lee et al., 1998; Rudel et al., 1998) . In addition, given that ROS activate MAPKKKs including c-FLIP suppresses caspase-dependent JNK and ROS A Nakajima et al apoptosis signal-regulating kinase (ASK)1 (Saitoh et al., 1998) , ASK1 might also contribute to prolonged JNK activation in c-FLIP knockdown cells. Moreover, the kinetics of ERK activation was earlier than the cleavage of MEKK1 (Figures 2a and 4a) . Collectively, MEKK1 is one of the kinases, but other kinase(s) might also contribute to prolonged JNK and ERK activation in response to TNFa in a caspase-dependent manner.
Contribution of the JNK pathway to TNFa-induced cell death has been highly debated. Several studies have shown that activation of the JNK pathway, especially prolonged JNK activation is essential for TNFa-and stress-induced cell death (Tournier et al., 2000; Tobiume et al., 2001; Deng et al., 2003) . In contrast, the JNKdependent pathway might not play a crucial role in TNFa-induced cell death in c-FLIP knockdown cells ( Figure 5 ). Under the conditions, in which c-FLIP L is downregulated, prolonged JNK activation is a downstream event of activation of the caspase cascade (Figures 2, 3 and 5) . Therefore, inhibition of the JNK pathway did not suppress TNFa-induced caspase activation and cell death in c-FLIP knockdown cells ( Figure 5 ). Taken that prolonged JNK activation enhances activity of an E3 ligase, itchy homolog E3 ubiquitin protein ligase (ITCH), which subsequently degrades c-FLIP L in primary hepatocytes together (Chang et al., 2006) , one possible scenario to explain these discrepancies would be that proapoptotic function of JNK might be largely mediated through degradation of c-FLIP L . Consistently, a previous study has shown that, in the absence of c-FLIP L , the TNFa-induced signaling complex II containing FADD and caspase 8/10 easily forms, resulting in apoptosis (Micheau and Tschopp, 2003) .
While necrosis is characterized by vacuolation of the cytoplasm, cytoplasmic vacuoles are also detected in cells undergoing autophagy. Autophagy is a major intracellular degradation mechanism for longed-lived proteins and organelles, and operates and promotes survival during starvation (Ohsumi, 2001; Levine and Klionsky, 2004) . During autophagy, vacuoles engulfed cytoplasmic organelles appear and are called autophagosomes. Recent studies have shown that autophagy is also associated with nonapoptotic cell death (Edinger and Thompson, 2004; Levine and Yuan, 2005) , prompting us to test whether TNFa-induced vacuoles are associated with autophagy. However, our preliminary experiments could not detect a punctate pattern of LC3 (Light-chain 3), a hallmark of autophagosome, in c-FLIP knockdown HeLa cells (data not shown). Therefore, these vacuoles in c-FLIP knockdown cells might not be associated with autophagy.
The most important findings of our study are that TNFa induces caspase-dependent JNK activation and ROS accumulation in several tumor cells followed by necrotic cell death, in which the expression of c-FLIP is downregulated. Upregulation of c-FLIP is frequently observed in various type tumors and might be responsible for escaping from death receptor-induced cell death (Djerbi et al., 1999; Medema et al., 1999; Budd et al., 2006) . Therefore, downregulation of c-FLIP by RNAi might be a promising strategy to treat these tumors through promoting caspase-dependent cell death. On the other hand, inflammatory responses to stressmediated or oncogene-activated necrosis in tumors stimulate angiogenesis and tumor cell proliferation (Balkwill and Coussens, 2004; Vakkila and Lotze, 2004) . Moreover, cell death, especially necrotic cell death of tumors promotes inflammatory responses accompanied with compensatory proliferation . While the release of a DNA-binding protein of High-mobility group box 1 protein from necrotic cells might play a dominant role in eliciting inflammatory responses in the surrounding tissues, production of ROS also induces inflammation and elicits DNA damage (Vakkila and Lotze, 2004) . Collectively, accumulated ROS and/or necrotic cell death associated with tumor therapy might induce DNA damage and inflammation, resulting in compensatory proliferation of tumor cells. In this respect, elucidating the mechanism underlying caspase-dependent ROS accumulation will be crucial to prevent this potential side effect induced by apoptosis promoting tumor therapy.
Materials and methods
Reagents and cell culture
Recombinant human TNFa were purchased from BD Biosciences (San Jose, CA, USA). BHA, z-VAD-fmk, Ac-IETD-CHO, 5-(and-6)-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA) and SP600125 were purchased from Wako (Osaka, Japan), Peptide Institute (Osaka, Japan), Molecular Probes (Eugene, OR, USA), Sigma-Aldrich (St Louis, MO, USA). Anti-c-FLIP (Alexis, Lausanne, Switzerland), anti-RIP (BD Biosciences), anti-TRAF2 (BD Biosciences), anti-XIAP (BD Biosciences), anti-caspase 8 (Cell Signaling Technology, Beverly, MA, USA), anti-Fas (MBL, Nagoya, Japan), anti-MEKK1 and anti-IkBa (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and anti-tubulin (Sigma-Aldrich) antibodies were purchased from the indicated sources. Antibodies specific for phospho-JNK, phospho-ERK, total JNK and total ERK were purchased from Cell Signaling Technology. HeLa cells were cultured in high-glucose Dulbecco's modified Eagle's medium containing 10% fetal calf serum (FCS). A549 cells were cultured in RPMI1640 containing 10% FCS. HCT116 cells were cultured in McCoy's 5A containing 10% FCS.
Measurement of ROS accumulation
Cells (2-5 Â 10 5 cells) were stimulated with TNFa or anti-Fas antibody for the indicated times, and then labeled with CM-H 2 DCFDA (1 mM) for 30 min at 371C. The cells were analysed on a flow cytometer (FACSCalibur, BD Biosciences). Data were processed by using the CellQuest program (BD Biosciences).
Western blotting Cells (5 Â 10 5 cells) were lysed in RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate, 25 mM b-glycerophosphate, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin and 1 mg/ml leupeptin). Western blotting was performed as described previously (Sakon et al., 2003) .
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Small interfering RNAs
HeLa, HCT116 and A549 cells (2-4 Â 10 6 cells) were transfected with siRNA oligos using Nucleofector (Amaxa, GmbH, Cologne, Germany). Duplex siRNA oligos with two nucleotides overhang at the 3 0 -end of the sequence were purchased from Qiagen (Valencia, CA, USA). The target sequences were as follows: human c-FLIP (a), 5 0 -GGAGCAGGGACAAG UUACA-3 0 ; human c-FLIP (b), 5 0 -GCAAGGAGAAGAGUU UCUU-3 0 ; GFP, 5 0 -GGCUACGUCCAGGAGCGCACC-3 0 . To evaluate the transfection efficiency of siRNA oligos, the cells were transfected with an expression vector for GFP, and GFP-positive cells were analysed by flow cytometry. The transfection efficiency was more than 80% based on GFPpositive cells.
WST assay HeLa (1 Â 10 4 cells) were plated in 96-well plates and cultured for 12 h. Then the cells were stimulated with TNFa (10 ng/ml) in the presence or absence of various inhibitors for 16 h. Cell viability was determined by water-soluble tetrazolium salt (WST) assay using a Cell Counting kit (Dojindo, Kumamoto, Japan).
Electron microscopy c-FLIP siRNA-transfected HeLa, HCT116 and A549 cells (4 Â 10 6 cells) were unstimulated or stimulated with TNFa in the presence or absence of z-VAD-fmk for 4 h, and then serially fixed with 2% glutaraldehyde in PBS for 2 h and then with 2% OsO 4 for 2 h before embedding in Epon 812. Thin sections were prepared using an MT-5000 ultramicrotome (Dupont Pharmaceuticals, Wilmington, DE, USA), stained with uranyl acetate followed by lead citrate, and then observed on a JEM1230 electron transmission microscope (JEOL).
Measurement of DNA hypoploidy DNA hypoploidy was measured as described previously (Nakayama et al., 2002) . In brief, control siRNA-or c-FLIP siRNA-transfected HeLa and HCT116 cells (4 Â 10 5 cells) were untreated or treated with TNFa (10 ng/ml) for the indicated times. Then, the cells were harvested and incubated in a buffer containing 50 mg/ml propidium iodide, 0.05% NP-40, 4 mM sodium citrate (pH 7.2) and 450 mg/ml RNase for 10 min at 41C, followed by the addition of 1.5 M NaCl. The cells were analysed on a FACSCalibur. Data were processed by using the CellQuest program.
LDH release assay LDH release assay was performed using cytotoxicity detection kit (LDH) according to the manufacturer's instruction (Roche Diagnostics GmbH, Mannheim, Germany). Briefly, control siRNA-or c-FLIP siRNA-transfected HeLa and HCT116 cells (4 Â 10 5 cells) were untreated or treated with TNFa (10 ng/ml) for the indicated times. Then, the culture supernatants were collected and LDH activities were determined by incubating with LDH substrates and measured by a spectrophotometer (Bio-Rad, Hercules, CA, USA). The percentage of LDH release (% LDH) was calculated by the following formula. % LDH release ¼ (LDH activity at the indicated times-LDH activity at time 0) Â 100/(maximal LDH activity-LDH activity at time 0). Triton-X 100 was added to a final concentration of 1% for the determination of maximal release of LDH activity.
Statistical analysis
Statistical analysis was performed by Student t-test. P value o0.05 was considered to be significant.
